Figure 1 from: Koleva K, Todorova L, Marchev S, Vlaskovska M, Nikolov R (2020) Pharmacovigilance: procedures for uniform assessment of periodic safety update reports and their implementation in national settings. Focus on analgesics. Pharmacia 67(4): 283-288. https://doi.org/10.3897/pharmacia.67.e57134

Figure 1 Distribution of discrepancies by type of active substance for all active substances/products affected by the PSUR evaluation procedures. Legend: I: Total number of products by active substances; II: The change has not been implemented; III: The change is implemented by an appropriate procedure; IV: The change is implemented outside the specified deadlines.